{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:56:27Z","timestamp":1791204987346,"version":"4.1.0"},"reference-count":14,"publisher":"Central Research Institute for Epidemiology","issue":"4","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["virusjour.crie.ru"],"crossmark-restriction":false},"short-container-title":["Problems of Virology"],"abstract":"<jats:p>Introduction. Influenza A virus is considered a promising vector platform for the creation of recombinant vaccines due to its high immunogenicity and ability to induce a pronounced humoral and cellular immune response.\r\nThe aim of the study is to investigate the optimal cultivation parameters for recombinant influenza A virus strains expressing Mycobacterium bovis ESAT-6 and TB10.4 antigens.\r\nMaterials and methods. Cultivation conditions for recombinant influenza viruses A\/Ast\/PR8-NS124-ESAT6 and A\/Ast\/PR8-NS124-TB10.4, expressing the ESAT6 and TB10.4 proteins of M. bovis, were optimized. The viruses were produced by reverse genetics using an eight-plasmid system. Cultivation was performed in MDCK and Vero cell lines at varying temperatures (30\u201337 \u00b0C), incubation times, and trypsin concentrations.\r\nResults. It was established that maximum infectious and hemagglutinating titers were achieved when cultured in Vero cells at 37 \u00b0C for 72 hours. A decrease in temperature to 30\u201335 \u00b0C was accompanied by a decrease in viral replication. The Vero cell line demonstrated higher productivity compared to MDCK. Hemagglutinating activity correlated with the infectious titer. RT-PCR confirmed the stability of genetic inserts in the NS segment of the genome throughout the entire cultivation period. Temperature and cell line type significantly influence the reproduction of recombinant viruses. The advantage of Vero cells is due to their higher virus accumulation rate. The stability of the genetic inserts confirms the reliability of the resulting strains as vector systems.\r\nConclusion. Optimal conditions for culturing recombinant influenza viruses, ensuring high reproduction rates and genetic stability, have been identified. The results confirm the potential of using influenza vectors for developing tuberculosis vaccines and the feasibility of scaling up their production.<\/jats:p>","DOI":"10.36233\/0507-4088-373","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:45:12Z","timestamp":1789667112000},"page":"350-356","update-policy":"https:\/\/doi.org\/10.36233\/0372-9311-crossmark","source":"Crossref","is-referenced-by-count":0,"title":["The influence of cultivation parameters on the reproduction of recombinant influenza viruses expressing immunodominant proteins of &lt;i&gt;Mycobacterium bovis&lt;\/i&gt;"],"prefix":"10.36233","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5609-2491","authenticated-orcid":false,"given":"Ruslan T.","family":"Abitayev","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems National Holding \u00abQazBioPharm\u00bb"},{"name":"National Academy of Sciences of the Kyrgyz Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5623-7571","authenticated-orcid":false,"given":"Aisha U.","family":"Issabek","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems National Holding \u00abQazBioPharm\u00bb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7039-5621","authenticated-orcid":false,"given":"Ainur S.","family":"Nurpeisova","sequence":"additional","affiliation":[{"name":"Kazakh Research Veterinary Institute, National Holding \u00abQazBioPharm\u00bb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8543-4219","authenticated-orcid":false,"given":"Yerbol A.","family":"Bulatov","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems National Holding \u00abQazBioPharm\u00bb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2153-1365","authenticated-orcid":false,"given":"Bermet M.","family":"Khudaibergenova","sequence":"additional","affiliation":[{"name":"National Academy of Sciences of the Kyrgyz Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22004","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"de Vries R.D., Rimmelzwaan G.F. Viral vector-based influenza vaccines. Hum. Vaccin. Immunother. 2016; 12(11): 2881\u2013901. https:\/\/doi.org\/10.1080\/21645515.2016.1210729","DOI":"10.1080\/21645515.2016.1210729"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Sedova E.S., Shcherbinin D.N., Migunov A.I., Smirnov Yu.A., Loganov Yu.D., Shmarov M.M., et al. Recombinant influenza vaccines. Acta Naturae. 2012; 4(4): 17\u201327. https:\/\/elibrary.ru\/rtbzyd (in Russian)","DOI":"10.32607\/20758251-2012-4-4-17-27"},{"key":"ref3","unstructured":"Kaverin N.V., Rudneva I.A., Timofeeva T.A., Ignatieva A.V. Antigenic structure of influenza A virus hemagglutinin. Voprosy virusologii. 2012; (S1): 148\u201358. https:\/\/elibrary.ru\/qjanvp (in Russian)"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Sereinig S., Stukova M., Zabolotnyh N., Ferko B., Kittel C., Romanova J., et al. Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge. Clin. Vaccine Immunol. 2006; 13(8): 898\u2013904. https:\/\/doi.org\/10.1128\/cvi.00056-06","DOI":"10.1128\/CVI.00056-06"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Sergeeva M., Romanovskaya-Romanko E., Zabolotnyh N., Pulkina A., Vasilyev K., Shurigina A.P., et al. Mucosal influenza vector vaccine carrying TB10.4 and HspX antigens provides protection against Mycobacterium tuberculosis in mice and guinea pigs. Vaccines (Basel). 2021; 9(4): 394. https:\/\/doi.org\/10.3390\/vaccines9040394 https:\/\/elibrary.ru\/sedoqz","DOI":"10.3390\/vaccines9040394"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Sergeeva M.V., Pulkina A.A., Vasiliev K.A., Romanovskaya-Romanko E.A., Komissarov A.B., Kuchur O.A., et al. Safety and immunogenicity of cold-adapted recombinant influenza vector expressing ESAT-6 and Ag85\u0410 antigens of M. tuberculosis. Voprosy virusologii. 2017; 62(6): 266\u201372. https:\/\/doi.org\/10.18821\/0507-4088-2017-62-6-266-272 https:\/\/elibrary.ru\/zuqeuj (in Russian)","DOI":"10.18821\/0507-4088-2017-62-6-266-272"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Abay Zh., Nurpeisova A., Shorayeva K., Sadikaliyeva S., Yespembetov B., Syrym N., et al. Safety and protective efficacy of a candidate vector-based vaccine for bovine tuberculosis. Vaccines (Basel). 2025; 11(7): 1199. https:\/\/doi.org\/10.3390\/vaccines11071199 https:\/\/elibrary.ru\/avybwf","DOI":"10.3390\/vaccines11071199"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005856"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Swayne D.E., Suarez D.L. Highly pathogenic avian influenza. Rev. Sci. Tech. 2000; 19(2): 463\u201382. https:\/\/doi.org\/10.20506\/rst.19.2.1230 https:\/\/elibrary.ru\/yjbgjs","DOI":"10.20506\/rst.19.2.1230"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Lvov D.K., Kaverin N.V. Avian influenza in Northern Eurasia. Monographs in Virology. 2008; 27: 41\u201358. https:\/\/elibrary.ru\/mnpxbf","DOI":"10.1159\/000151607"},{"key":"ref11","unstructured":"Vasilyev Yu.M. Optimization of propagation of avian influenza viruses in various substrates and improvement of inactivated vaccines against avian influenza: Diss. Moscow; 2010. https:\/\/elibrary.ru\/qgvrxb (in Russian)"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Alizadeh F., Aghajani H., Mahboudi F., Talebkhan Y., Arefian E., Samavat S., et al. Optimization of culture condition for Spodoptera frugiperda by design of experiment approach and evaluation of its effect on the expression of hemagglutinin protein of influenza virus. PLoS One. 2024; 19(8): e0308547. https:\/\/doi.org\/10.1371\/journal.pone.0308547","DOI":"10.1371\/journal.pone.0308547"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938; 27(3): 493\u20137. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a118408","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Nurpeisova A., Abay Zh., Kassenov M., Syrym N., Sadikaliyeva S., Yespembetov B., et al. A novel influenza vector-based vaccine expressing ESAT-6 and TB10.4 confers immunity and protection against Bovine tuberculosis in guinea pigs and calves. Vet. World. 2025; 18(9): 2573\u201389. https:\/\/doi.org\/10.14202\/vetworld.2025.2573-2589 https:\/\/elibrary.ru\/ezygbt","DOI":"10.14202\/vetworld.2025.2573-2589"}],"container-title":["Problems of Virology"],"original-title":[],"link":[{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/viewFile\/16864\/1121","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/viewFile\/16864\/1121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:32:55Z","timestamp":1791203575000},"score":1,"resource":{"primary":{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/view\/16864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,9,17]]}},"URL":"https:\/\/doi.org\/10.36233\/0507-4088-373","relation":{},"ISSN":["2411-2097","0507-4088"],"issn-type":[{"value":"2411-2097","type":"electronic"},{"value":"0507-4088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}